首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Novel cis-selective and non-epimerisable C3 hydroxy azapodophyllotoxins targeting microtubules in cancer cells
【24h】

Novel cis-selective and non-epimerisable C3 hydroxy azapodophyllotoxins targeting microtubules in cancer cells

机译:靶向癌细胞中微管的新型顺式-选择性和不可泛化的C3羟基氮杂鬼臼毒素

获取原文
获取原文并翻译 | 示例
           

摘要

Podophyllotoxin (PT) and its clinically used analogues are known to be powerful antitumour agents. These compounds contain a trans fused strained gamma-lactone system, a feature that correlates to the process of epimerisation, whereby the trans gamma-lactone system of ring D opens and converts to the more thermodynamically stable cis epimer. Since these cis epimers are known to be either less active or lacking antitumour activity, epimerisation is an undesirable feature from a chemotherapeutic point of view. To circumvent this problem, considerable efforts have been reported, amongst which is the synthesis of azapodophyllotoxins where the stereocentres at C2 and C3 are removed in order to preclude epimerisation. Herein we report the identification of a novel C3 hydroxy, cis-selective gamma-lactone configuration of ring C in the azapodophyllotoxin scaffold, through an efficient stereoselective multicomponent reaction (MCR) involving fluorinated and non-fluorinated aldehydes. This configuration releases the highly strained trans gamma-lactone system in podophyllotoxin analogues into the more thermodynamically stable cis gamma-lactone motif and yet retains significantly potent activity. These compounds were evaluated against the human cancer lines MCF-7 and 22Rv1 in vitro. Fourteen out of the seventeen tested compounds exhibited sub-micromolar activity with IC50 values in the range of 0.11-0.91 mu M, which is comparable and in some cases better than the activity profile of etoposide in this assay. Interestingly, we obtained strong evidence from spectroscopic and X-ray data analyses that the previously reported structure of similar analogues is not accurate. Molecular modelling performed using the podophyllotoxin binding site on beta tubulin revealed a novel binding mode of these analogues. Furthermore, sub-cellular study of our compounds using immunolabelling and confocal microscopy analyses showed strong microtubule disruptive activity, particularly in dividing cells. (C) 2016 The Authors. Published by Elsevier Masson SAS.
机译:鬼臼毒素(PT)及其临床使用的类似物是有效的抗肿瘤药。这些化合物包含反式稠合的γ-内酯体系,该特征与差向异构化过程相关,其中D环的反式γ-内酯体系打开并转化为热力学更稳定的顺式差向异构体。由于已知这些顺式差向异构体的活性较低或缺乏抗肿瘤活性,因此从化疗的观点来看,差向异构化是不希望的特征。为了解决这个问题,已经报道了相当大的努力,其中包括合成脱氮鬼臼毒素,其中为了防止差向异构化而去除了C2和C3处的立体中心。在本文中,我们报告了通过一个有效的立体选择性多组分反应(MCR),涉及氟化和非氟化醛,确定了氮杂鬼臼毒素支架中C环的新型C3羟基,顺式选择性γ-内酯构型。这种构型将鬼臼毒素类似物中的高张力反式γ-内酯系统释放为热力学更稳定的顺式γ-内酯基序,但仍保留了显着的有效活性。这些化合物在体外针对人癌MCF-7和22Rv1进行了评估。在这17种测试化合物中,有14种表现出亚微摩尔活性,IC50值在0.11-0.91μM的范围内,在此试验中,这是可比的,在某些情况下优于依托泊苷的活性曲线。有趣的是,我们从光谱和X射线数据分析中获得了有力的证据,证明先前报道的类似物结构不准确。使用β微管蛋白上鬼臼毒素结合位点进行的分子建模揭示了这些类似物的新型结合方式。此外,使用免疫标记和共聚焦显微镜分析对我们的化合物进行的亚细胞研究显示出强大的微管破坏活性,尤其是在分裂细胞中。 (C)2016作者。由Elsevier Masson SAS发布。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号